Why Dynavax Technologies Is Jumping Today

Shares of the small-cap biotech Dynavax Technologies Corporation (NASDAQ: DVAX) are poised for a big day today. In pre-market action, the company's shares rose by as much as 43% on heavy volume. Investors are bidding up Dynavax's shares this morning in anticipation of the company's COVID-19 vaccine program update, which is scheduled for later today.

One of the main reasons for all the excitement is that Dynavax has already announced that one or more of its collaboration partners should initiate an early stage COVID-19 vaccine trial by July. Today's meeting will likely provide additional information on the state of these partnerships.

Image source: Getty Images.